Literature DB >> 24139861

2'-Hydroxy ceramide in membrane homeostasis and cell signaling.

Venkatesh Kota1, Hiroko Hama2.   

Abstract

Ceramide is a precursor of complex sphingolipids and also plays important roles in cell signaling. With the advances in lipid analytical technologies, the structural diversity of ceramide species have become evident, and the complexity of cellular metabolism and function associated with distinct ceramide species is beginning to be revealed. One of the common structural variations of ceramide is 2'-hydroxylation of the N-acyl chain. Fatty acid 2-hydroxylase (FA2H) is one of the enzymes that introduce the hydroxyl group during de novo synthesis of ceramide. FA2H is essential for the normal functioning of the nervous system, as evidenced by demyelinating disorder associated with FA2H mutations in humans and mice. Studies of Fa2h mutant mice indicate that lack of 2'-hydroxy galactosylceramide in the myelin membrane results in loss of long-term stability of myelin and eventual demyelination. FA2H also regulates differentiation of various cell types (epidermal keratinocytes, schwannoma cells, adipocytes). When provided exogenously, ceramide induces apoptosis in many cell types. Interestingly, the effective concentration of 2'-hydroxy ceramide that induces apoptosis is significantly lower compared to non-hydroxy ceramide, and cells die much more rapidly, suggesting that 2'-hydroxy ceramide can mediate proapoptotic signaling distinct from non-hydroxy ceramide. Collectively, current evidence clearly shows that 2'-hydroxy ceramide and 2'-hydroxy complex sphingolipids have unique functions in membrane homeostasis and cell signaling that could not be substituted by non-hydroxy counterparts.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24139861      PMCID: PMC3946364          DOI: 10.1016/j.jbior.2013.09.012

Source DB:  PubMed          Journal:  Adv Biol Regul        ISSN: 2212-4926


  44 in total

Review 1.  Barrier function of the skin: "la raison d'être" of the epidermis.

Authors:  Kathi C Madison
Journal:  J Invest Dermatol       Date:  2003-08       Impact factor: 8.551

2.  Cell cycle inhibitors p21 and p16 are required for the regulation of Schwann cell proliferation.

Authors:  Suzana Atanasoski; Danielle Boller; Lukas De Ventura; Heidi Koegel; Matthias Boentert; Peter Young; Sabine Werner; Ueli Suter
Journal:  Glia       Date:  2006-01-15       Impact factor: 7.452

3.  Central nervous system dysfunction in a mouse model of FA2H deficiency.

Authors:  Kathleen A Potter; Michael J Kern; George Fullbright; Jacek Bielawski; Steven S Scherer; Sabrina W Yum; Jian J Li; Hua Cheng; Xianlin Han; Jagadish Kummetha Venkata; P Akbar Ali Khan; Bärbel Rohrer; Hiroko Hama
Journal:  Glia       Date:  2011-04-13       Impact factor: 7.452

4.  Defective FA2H leads to a novel form of neurodegeneration with brain iron accumulation (NBIA).

Authors:  Michael C Kruer; Coro Paisán-Ruiz; Nathalie Boddaert; Moon Y Yoon; Hiroko Hama; Allison Gregory; Alessandro Malandrini; Randall L Woltjer; Arnold Munnich; Stephanie Gobin; Brenda J Polster; Silvia Palmeri; Simon Edvardson; John Hardy; Henry Houlden; Susan J Hayflick
Journal:  Ann Neurol       Date:  2010-11       Impact factor: 10.422

5.  Fatty acid 2-hydroxylase, encoded by FA2H, accounts for differentiation-associated increase in 2-OH ceramides during keratinocyte differentiation.

Authors:  Yoshikazu Uchida; Hiroko Hama; Nathan L Alderson; Sounthala Douangpanya; Yu Wang; Debra A Crumrine; Peter M Elias; Walter M Holleran
Journal:  J Biol Chem       Date:  2007-03-12       Impact factor: 5.157

6.  Fatty acid 2-hydroxylase mediates diffusional mobility of Raft-associated lipids, GLUT4 level, and lipogenesis in 3T3-L1 adipocytes.

Authors:  Lin Guo; Dequan Zhou; Kenneth M Pryse; Adewole L Okunade; Xiong Su
Journal:  J Biol Chem       Date:  2010-06-02       Impact factor: 5.157

7.  Absence of 2-hydroxylated sphingolipids is compatible with normal neural development but causes late-onset axon and myelin sheath degeneration.

Authors:  Inge Zöller; Marion Meixner; Dieter Hartmann; Heinrich Büssow; Rainer Meyer; Volkmar Gieselmann; Matthias Eckhardt
Journal:  J Neurosci       Date:  2008-09-24       Impact factor: 6.167

8.  2'-hydroxy C16-ceramide induces apoptosis-associated proteomic changes in C6 glioma cells.

Authors:  Venkatesh Kota; Vishnu M Dhople; George Fullbright; Nancy M Smythe; Zdzislaw M Szulc; Alicja Bielawska; Hiroko Hama
Journal:  J Proteome Res       Date:  2013-09-12       Impact factor: 4.466

9.  Induction of apoptotic DNA fragmentation and cell death by natural ceramide.

Authors:  L Ji; G Zhang; S Uematsu; Y Akahori; Y Hirabayashi
Journal:  FEBS Lett       Date:  1995-01-23       Impact factor: 4.124

10.  Mutations in the fatty acid 2-hydroxylase gene are associated with leukodystrophy with spastic paraparesis and dystonia.

Authors:  Simon Edvardson; Hiroko Hama; Avraham Shaag; John Moshe Gomori; Itai Berger; Dov Soffer; Stanley H Korman; Ilana Taustein; Ann Saada; Orly Elpeleg
Journal:  Am J Hum Genet       Date:  2008-11       Impact factor: 11.025

View more
  20 in total

1.  The ceramide moiety of disialoganglioside (GD3) is essential for GD3 recognition by the sialic acid-binding lectin SIGLEC7 on the cell surface.

Authors:  Noboru Hashimoto; Shizuka Ito; Akiko Tsuchida; Robiul H Bhuiyan; Tetsuya Okajima; Akihito Yamamoto; Keiko Furukawa; Yuhsuke Ohmi; Koichi Furukawa
Journal:  J Biol Chem       Date:  2019-05-28       Impact factor: 5.157

Review 2.  Intra- and intercellular trafficking in sphingolipid metabolism in myelination.

Authors:  Binks W Wattenberg
Journal:  Adv Biol Regul       Date:  2018-11-23

3.  Hypoxia remodels the composition of the constituent ceramide species of HexCer and Hex2Cer with phytosphingosine and hydroxy fatty acids in human colon cancer LS174T cells.

Authors:  Kouji Tanaka; Keiko Tamiya-Koizumi; Masaki Yamada; Takashi Murate; Reiji Kannagi; Mamoru Kyogashima
Journal:  Glycoconj J       Date:  2015-07-22       Impact factor: 2.916

4.  Hexosylceramides and Glycerophosphatidylcholine GPC(36:1) Increase in Multi-Organ Dysfunction Syndrome Patients with Pediatric Intensive Care Unit Admission over 8-Day Hospitalization.

Authors:  Mara Leimanis-Laurens; Emily Wolfrum; Karen Ferguson; Jocelyn R Grunwell; Dominic Sanfilippo; Jeremy W Prokop; Todd A Lydic; Surender Rajasekaran
Journal:  J Pers Med       Date:  2021-04-24

5.  An Arabidopsis neutral ceramidase mutant ncer1 accumulates hydroxyceramides and is sensitive to oxidative stress.

Authors:  Jian Li; Fang-Cheng Bi; Jian Yin; Jian-Xin Wu; Chan Rong; Jia-Li Wu; Nan Yao
Journal:  Front Plant Sci       Date:  2015-06-19       Impact factor: 5.753

6.  Use of Metabolomics as a Complementary Omic Approach to Implement Risk Criteria for First-Degree Relatives of Gastric Cancer Patients.

Authors:  Giuseppe Corona; Renato Cannizzaro; Gianmaria Miolo; Laura Caggiari; Mariangela De Zorzi; Ombretta Repetto; Agostino Steffan; Valli De Re
Journal:  Int J Mol Sci       Date:  2018-03-07       Impact factor: 5.923

7.  Nimodipine but Not Nifedipine Promotes Expression of Fatty Acid 2-Hydroxylase in a Surgical Stress Model Based on Neuro2a Cells.

Authors:  Eva Herzfeld; Lea Speh; Christian Strauss; Christian Scheller
Journal:  Int J Mol Sci       Date:  2017-05-03       Impact factor: 5.923

8.  Mitochondrial dysfunction and defects in lipid homeostasis as therapeutic targets in neurodegeneration with brain iron accumulation.

Authors:  Kerri J Kinghorn; Jorge Iván Castillo-Quan
Journal:  Rare Dis       Date:  2016-01-25

9.  Ganglioside GM2: a potential biomarker for cholangiocarcinoma.

Authors:  Krajang Talabnin; Chutima Talabnin; Tadahiro Kumagai; Nuchanard Sutatum; Juthamas Khiaowichit; Chawaboon Dechsukhum; Mayumi Ishihara; Parastoo Azadi; Banchob Sripa
Journal:  J Int Med Res       Date:  2020-07       Impact factor: 1.671

Review 10.  Defective lipid metabolism in neurodegeneration with brain iron accumulation (NBIA) syndromes: not only a matter of iron.

Authors:  Cristina Colombelli; Manar Aoun; Valeria Tiranti
Journal:  J Inherit Metab Dis       Date:  2014-10-10       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.